Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

WW van Willigen; M Bloemendal; MJ Boers-Sonderen; Jan-Willem B de Groot; RH Koornstra; Astrid Veldt; J Haanen; S Boudewijns; G Schreibelt; WR Gerritsen; IJM de Vries; KF Bol

doi:10.1080/2162402x.2020.1738814

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

WW van Willigen, M Bloemendal, MJ Boers-Sonderen, Jan-Willem B de Groot, RH Koornstra, Astrid Veldt, J Haanen, S Boudewijns, G Schreibelt, WR Gerritsen, IJM de Vries, KF Bol

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

24 Downloads (Pure)

Original language	English
Article number	1738814
Journal	OncoImmunology
Volume	9
Issue number	1
DOIs	https://doi.org/10.1080/2162402x.2020.1738814
Publication status	Published - 2020

Research programs

EMC NIHES-03-30-02
EMC OR-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/2162402x.2020.1738814

Repub_130608_O-A.pdfFinal published version, 2.13 MB

Cite this

van Willigen, WW., Bloemendal, M., Boers-Sonderen, MJ., de Groot, J.-W. B., Koornstra, RH., Veldt, A., Haanen, J., Boudewijns, S., Schreibelt, G., Gerritsen, WR., de Vries, IJM., & Bol, KF. (2020). Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination. OncoImmunology, 9(1), Article 1738814. https://doi.org/10.1080/2162402x.2020.1738814

@article{5de0baee7d6a43e799fe86d2919ce5c0,

title = "Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination",

author = "{van Willigen}, WW and M Bloemendal and MJ Boers-Sonderen and {de Groot}, {Jan-Willem B} and RH Koornstra and Astrid Veldt and J Haanen and S Boudewijns and G Schreibelt and WR Gerritsen and {de Vries}, IJM and KF Bol",

year = "2020",

doi = "10.1080/2162402x.2020.1738814",

language = "English",

volume = "9",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "1",

}

van Willigen, WW, Bloemendal, M, Boers-Sonderen, MJ, de Groot, J-WB, Koornstra, RH, Veldt, A, Haanen, J, Boudewijns, S, Schreibelt, G, Gerritsen, WR, de Vries, IJM & Bol, KF 2020, 'Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination', OncoImmunology, vol. 9, no. 1, 1738814. https://doi.org/10.1080/2162402x.2020.1738814

TY - JOUR

T1 - Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination

AU - van Willigen, WW

AU - Bloemendal, M

AU - Boers-Sonderen, MJ

AU - de Groot, Jan-Willem B

AU - Koornstra, RH

AU - Veldt, Astrid

AU - Haanen, J

AU - Boudewijns, S

AU - Schreibelt, G

AU - Gerritsen, WR

AU - de Vries, IJM

AU - Bol, KF

PY - 2020

Y1 - 2020

U2 - 10.1080/2162402x.2020.1738814

DO - 10.1080/2162402x.2020.1738814

M3 - Article

SN - 2162-4011

VL - 9

JO - OncoImmunology

JF - OncoImmunology

IS - 1

M1 - 1738814

ER -